<DOC>
	<DOCNO>NCT01415102</DOCNO>
	<brief_summary>The purpose study healthy people evaluate safety , toleration time course plasma concentration single inhaled dos PF-05212372 .</brief_summary>
	<brief_title>A First In Human Study In Healthy People To Evaluate Safety , Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372 .</brief_title>
	<detailed_description />
	<criteria>Healthy subject . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen . Treatment investigational drug within past 30 day ( local regulation ) 5 halflives precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>